Helen Pentikis
Oprichter bij Zero Point Five Therapeutics, Inc.
Profiel
Helen S.
Pentikis is the founder and Chief Executive Officer & Chief Scientific Officer of SAJE Pharma LLC since 2011.
She is also the founder of Zero Point Five Therapeutics, Inc., GSNO Therapeutics, Inc. Helen's current job is Chief Scientific Officer at Symbiomix Therapeutics LLC.
Her former job was Chief Scientific Officer at Processa Pharmaceuticals, Inc. Helen received her undergraduate degree from Wake Forest University and her doctorate from the University of Maryland.
Actieve functies van Helen Pentikis
Bedrijven | Functie | Begin |
---|---|---|
Symbiomix Therapeutics LLC
Symbiomix Therapeutics LLC BiotechnologyHealth Technology Symbiomix Therapeutics LLC develops medicines for women’s health infections and related diseases. It offers SYM-1219, a drug that contains secnidazole that facilitate administration as a single-dose oral therapy for various women's health infections including bacterial vaginosis. The company was founded by Jack Roberts, Steve Pomerantz and Joseph L. Amprey III in 2012 and is headquartered in Newark, NJ. | Hoofd Techniek/Wetenschap/O&O | - |
SAJE Pharma LLC
SAJE Pharma LLC Pharmaceuticals: MajorHealth Technology SAJE Pharma LLC operates as a biopharmaceutical company. It focuses on developing new therapeutic agents that provide significant benefits over available therapies for rare and common diseases with unmet medical needs. The company was founded by Matthews O. Bradley and Helen S. Pentikis in 2011 and is headquartered in Baltimore, MD. | Algemeen Directeur | 01-01-2011 |
Zero Point Five Therapeutics, Inc.
Zero Point Five Therapeutics, Inc. BiotechnologyHealth Technology Zero Point Five Therapeutics, Inc. is a drug development company that focuses on neglected tropical diseases and soil-transmitted helminthiasis. The company is based in Baltimore, MD. The company was founded by Helen S. Pentikis, Joseph L. Amprey. Joseph L. Amprey has been the CEO since incorporation. | Oprichter | - |
Eerdere bekende functies van Helen Pentikis
Bedrijven | Functie | Einde |
---|---|---|
PROCESSA PHARMACEUTICALS, INC. | Hoofd Techniek/Wetenschap/O&O | - |
Opleiding van Helen Pentikis
Wake Forest University | Undergraduate Degree |
University of Maryland | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
PROCESSA PHARMACEUTICALS, INC. | Health Technology |
Bedrijven in privébezit | 3 |
---|---|
SAJE Pharma LLC
SAJE Pharma LLC Pharmaceuticals: MajorHealth Technology SAJE Pharma LLC operates as a biopharmaceutical company. It focuses on developing new therapeutic agents that provide significant benefits over available therapies for rare and common diseases with unmet medical needs. The company was founded by Matthews O. Bradley and Helen S. Pentikis in 2011 and is headquartered in Baltimore, MD. | Health Technology |
Symbiomix Therapeutics LLC
Symbiomix Therapeutics LLC BiotechnologyHealth Technology Symbiomix Therapeutics LLC develops medicines for women’s health infections and related diseases. It offers SYM-1219, a drug that contains secnidazole that facilitate administration as a single-dose oral therapy for various women's health infections including bacterial vaginosis. The company was founded by Jack Roberts, Steve Pomerantz and Joseph L. Amprey III in 2012 and is headquartered in Newark, NJ. | Health Technology |
Zero Point Five Therapeutics, Inc.
Zero Point Five Therapeutics, Inc. BiotechnologyHealth Technology Zero Point Five Therapeutics, Inc. is a drug development company that focuses on neglected tropical diseases and soil-transmitted helminthiasis. The company is based in Baltimore, MD. The company was founded by Helen S. Pentikis, Joseph L. Amprey. Joseph L. Amprey has been the CEO since incorporation. | Health Technology |